Results 231 to 240 of about 94,021 (297)

Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models. [PDF]

Cell Mol Neurobiol
Vu H, George N, Xiao J.
europepmc   +1 more source

Digital Twins in Clinical Neurology: From Concept to Clinical Application in Multiple Sclerosis

European Journal of Neurology, Volume 33, Issue 11, November 2026.
ABSTRACT Introduction Patient digital twins (DT) are emerging as a promising paradigm for personalised and predictive healthcare. In neurology, and particularly in multiple sclerosis (MS), the availability of longitudinal, multimodal data provides a strong foundation for developing patient‐specific digital models, including simulation‐based and ...
Isabel Voigt, Hernan Inojosa, Judith Wenk, Iva Gasparovic‐Curtini, Sergiu Groppa, Matthias Grothe, Marc Pawlitzki, Lars Masanneck, Sven Meuth, Stephen Gilbert, Tjalf Ziemssen   +10 more
wiley   +1 more source

On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis. [PDF]

Emerg Med J
Matrisch L, Rau Y, Graßhoff L, Nitschke M.   +3 more
europepmc   +1 more source

Ultra‐Weak Photon Emission as a By‐Product of Mitochondrial Oxidative Metabolism: Mechanisms, Limits, and Implications

Nanophotonics, Volume 15, Issue 20, 27 October 2026.
Mitochondrial oxidative metabolism generates ROS. Downstream chemiexcitation triplet carbonyls, singlet oxygen; produces ultra‐weak photon emission (UPE). Energetic bounds restrict well‐coupled respiration to extremely weak, red/NIR‐biased emission. Stronger visible UPE indicates elevated oxidative flux, linking measured photon counts to redox state ...
Samuel Crowther, Alice Attenborough, Frank Vollmer   +2 more
wiley   +1 more source

CSF1R inhibition following antibody mediated demyelination has limited impact on remyelination. [PDF]

Acta Neuropathol Commun
Golden LC, Peet GC, Rodriguez RE, Jahahn NJ, Owens GP, Bennett JL, Macklin WB.   +6 more
europepmc   +1 more source

Therapeutic Effects of Combined 6-Shogaol and Ibudilast on Neuroinflammation and Behavioral Deficits in a Cuprizone Mouse Model of Multiple Sclerosis. [PDF]

Pharmaceuticals (Basel)
Alshahrany GA, Alyami KA, Alzahrani NA, Alam MZ, Alghamdi BS, Omar UM, Banjabi AA, Alshaibi HF, Jambi RJ, Al-Otaibi KM, Alsufiani HM.   +10 more
europepmc   +1 more source

CD44 as a Conserved Biomarker and Functional Modulator of Neuroinflammation in Multiple Sclerosis and Beyond. [PDF]

Mol Neurobiol
Behrangi N, Stadler MS, Reinbach C, Burkert L, Hawlitschka A, Kaddatz H, Wenzel L, Llovera G, Wree A, Hoornaert C, Ponsaerts P, Splietker U, Brandenburg LO, Amor S, Tauber SC, Bohn A, Schmitz C, Kipp M, Hochstrasser T.   +18 more
europepmc   +1 more source

Osmotic Demyelination Syndrome in an Alcohol-Dependent Patient With Alcohol-Related Peripheral Neuropathy: A Case Report. [PDF]

Cureus
Itagaki H, Endo T.
europepmc   +1 more source

Oligodendrocyte and Astrocyte Dynamics During Short-Term Cuprizone Treatment. [PDF]

Brain Behav
Frankle L, Oso M, Riley A, Tomor R, Checan DC, Lee H, Jarzembak K, Sternbach S, Shelestak J, McDonough J, Clements R.   +10 more
europepmc   +1 more source